Low Rates of Postpartum Glucose Screening Among Indigenous and non-Indigenous Women in Australia with Gestational Diabetes
Catherine Chamberlain, Anna McLean, Jeremy Oats, Brian Oldenburg, Sandra Eades, Ashim Sinha, Rory Wolfe
MATERNAL AND CHILD HEALTH JOURNAL | SPRINGER/PLENUM PUBLISHERS | Published : 2015
Women with gestational diabetes have a high risk of type 2 diabetes postpartum, with Indigenous women particularly affected. This study reports postpartum diabetes screening rates among Indigenous and non-Indigenous women with gestational diabetes, in Far North Queensland, Australia. Retrospective study including 1,012 women with gestational diabetes giving birth at a regional hospital from 1/1/2004 to 31/12/2010. Data were linked between hospital records, midwives perinatal data, and laboratory results, then analysed using survival analysis and logistic regression. Indigenous women had significantly longer times to first oral glucose tolerance test (OGTT) [hazards ratio (HR) 0.62, 95 % conf..View full abstract
Awarded by National Health and Medical Research Council PhD scholarship
We are grateful to the Cairns Diabetes Centre for providing financial assistance to enable reviews of some medical records for this project. This project would not be possible without the support of all other members of the Project Advisory Committee, including Professor Bronwyn Fredericks, and Dr. Jacqueline Mein. We thank Ms. Nancy Goncalves for assisting with data collection. We especially thank Ms. Philippa Loane from the Clinical Informatics and Data Management Unit, Monash University for assistance establishing a Microsoft Access database. Thankyou to Paul Ishiguchi for reviewing other diabetes screening guidelines. We appreciate and acknowledge the following organisations providing data for this project: the Cairns Base Hospital Casemix and Clinical Costing Unit, the Cairns Base Hospital Health Information Services, the Health Statistics Unit (Queensland Health), Queensland Health Primary Healthcare Information Service, Sullivan and Nicolaides Laboratories, and Queensland Medical Laboratories. Catherine Chamberlain is a PhD candidate, supported by a National Health and Medical Research Council PhD scholarship (607247).